GlassScriptPhysician profile
Omar Nadra
NPI 1114334828
$2,875.32
in general payments reported to CMS, 2019-2025
12 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $47.01 · 2021: $1,360 · 2022: $96.98 · 2023: $748 · 2024: $231 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $912.50 | 2021-2025 | Endurant Iis, Turbohawk, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $815.86 | 2021-2024 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $303.02 | 2021-2022 | |
| Boston Scientific Corporation | $169.83 | 2021-2023 | Eluvia |
| Medtronic Vascular, INC. | $131.95 | 2019-2020 | |
| Abbott Laboratories | $119.40 | 2019-2025 | Perclose Proglide |
| Terumo Medical Corporation | $102.83 | 2021-2025 | Azur Cx Detachable |
| Penumbra, INC. | $90.51 | 2021 | |
| Cook Medical LLC | $82.40 | 2023 | Zenith Spiral-Z |
| Lemaitre Vascular, INC. | $71.98 | 2022 | |
| Inari Medical, INC. | $48.78 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Davol INC. | $26.26 | 2025 | Progel Applicator Spray Tips |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Nadra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.